Insiders · Profile

Larkin Cristina

Chief Operating Officer at Spero Therapeutics. Filing since 6 Nov 2017. CIK 0001721173

Company
Date
Role
Action
Shares
Amount
Of holding
16 Dec 2020
Chief Operating Officer
Sold, plan not stated
12,000
$228.00K
88.9%
5 Jul 2018
Chief Operating Officer
Sold, plan not stated
4,000
$70.00K
72.7%
6 Nov 2017
Chief Operating Officer
Bought
1,500
$21.00K
opened
3 decisions on file.